Edgewise Therapeutics, Inc. (EWTX) NASDAQ
31.58
+0.35(+1.12%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
31.58
+0.35(+1.12%)
Currency In USD
| Market Cap | 2.55B |
| Enterprise Value | 2.5B |
| P/E Ratio | -19.37 |
| PEG Ratio | 1.67 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.22 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -18.56 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.3 |
| Return On Equity | -0.32 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.27M |
| EBITDA | -165.53M |
| Net Income | -167.8M |
| Diluted EPS | -1.63 |
| Total Cash | 530.11M |
| Total Cash/Share | 5.15 |
| Total Debt | 3.99M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 19.85 |
| Book Value Per Share | 5.07 |
| 52-Week Change | 112.8 |
| 52-Week High | 35 |
| 52-Week Low | 12.15 |
| Moving Average 50 Days | 30.99 |
| Moving Average 200 Days | 22.17 |
| Average Volume | 849,655 |
| Shares Outstanding | 107.27M |
| % Held by Institutions | 115.48 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |